Inhibitors of intravesicular acidification protect against Shiga toxin in a pH-independent manner.
| Autor: | Dyve Lingelem AB; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway., Bergan J, Sandvig K |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Traffic (Copenhagen, Denmark) [Traffic] 2012 Mar; Vol. 13 (3), pp. 443-54. Date of Electronic Publication: 2011 Dec 21. |
| DOI: | 10.1111/j.1600-0854.2011.01319.x |
| Abstrakt: | Shiga toxin inhibits protein synthesis after being transported from the cell surface to endosomes and retrogradely through the Golgi apparatus to the endoplasmic reticulum (ER) and into the cytosol. In this study, we have abolished proton gradients across internal membranes in different ways and investigated the effect on the various transport steps of Shiga toxin. Although inhibitors of the proton pump such as bafilomycin A1 and concanamycin A as well as some ionophores and chloroquine all protect against Shiga toxin, they mediate protection by inhibiting different transport steps. For instance, chloroquine protects the cells, although the toxin is transported to the ER. Importantly, our data indicate that proton pump activity is required for efficient endosome-to-Golgi transport of Shiga toxin, although acidification as such does not seem to be required. (© 2011 John Wiley & Sons A/S.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|